FDA to review inhaled caffeine product

According to the Associated Press, the FDA will investigate the safety of Aeroshot inhalable caffeine and whether the product can be considered a dietary supplement as the manufacturer claims or if it is subject to regulation as a drug. AeroShot is manufactured by Breathable Foods, co-founded by Harvard professor David Edwards.

The report says that FDA Commissioner Margaret Hamburg has agreed to review the legality of AeroShot and its safety after meeting with Sen. Charles Schumer of New York who has been a vocal critic of the product.

Breathable Foods CEO Tom Hadfield issued a statement indicating the company’s confidence in the safety of the product and its intention to cooperate with the FDA investigation.

Read the Associated Press article.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan